Barclays analyst Raimo Lenschow raised the firm’s price target on Confluent to $26 from $24 and keeps an Overweight rating on the shares. The main news from the Q4 results was the source of booking weakness and it seems deal slippage in the enterprise segment for Confluent Platform was the main issue, the analyst tells investors in a research note. The firm thinks the bookings deceleration is more a representation of the tougher environment that will be felt by more companies. It continues to like Confluent’s long-term story.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CFLT:
- Confluent (NASDAQ: CFLT) Delivers Splendid Q4 Numbers
- Confluent backs FY23 EPS view (28c)-(22c), consensus (43c)
- Confluent sees Q1 adjusted EPS (15c)-(13c), consensus (15c)
- Confluent reports Q4 adjusted EPS (9c), consensus (14c)
- Confluent options imply 9.6% move in share price post-earnings
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue